The nation's leading gastroenterology professional society released updated colon cancer screening guidelines Thursday, recommending that average-risk adults begin screening at age 40 -- five years earlier than the threshold established just six years ago -- in response to what researchers describe as an unmistakable and deeply concerning increase in colorectal cancer diagnoses among adults under 50.
The change reflects a significant shift in the epidemiology of colorectal cancer over the past decade. While rates of the disease in older adults have been declining steadily, driven in part by effective screening programs, rates among adults under 50 have risen by approximately 2% per year since the late 1990s, with the increase accelerating in the most recent cohort data. Researchers do not fully understand the causes of this trend, though dietary factors, changes in the gut microbiome, obesity rates, and sedentary behavior have all been proposed as contributing factors.
"What we know with confidence is that we are seeing more of these cancers in people in their 30s and 40s, and that they are frequently caught at late stages because those patients are not being screened," said the chair of the guideline writing committee. "The update reflects a straightforward application of the evidence: if the disease is presenting earlier, screening needs to start earlier." The new recommendation applies to adults at average risk, defined as those without a personal or family history of colorectal cancer or polyps, inflammatory bowel disease, or inherited syndromes associated with increased risk, who already qualify for earlier and more frequent screening.
“If the disease is presenting earlier, screening needs to start earlier. This is a straightforward application of the evidence to protect the people we are now seeing in our clinics.”
— Chair, guideline writing committee
The practical implications of the change are significant. An estimated 20 million adults between the ages of 40 and 44 would newly fall within the recommended screening window, creating a substantial expansion in demand for colonoscopies, CT colonography, and stool-based testing. Healthcare systems and insurance providers will need to assess capacity and coverage accordingly, and several health policy analysts noted that equitable access to the expanded screening will require deliberate effort to reach populations that face barriers to preventive care.
Insurance coverage questions are expected to dominate the near-term implementation discussion. Preventive services that carry a grade A or B recommendation from the independent task force on preventive services are generally covered without cost-sharing under current law, and advocates said the professional society guidelines should provide momentum for the task force to follow with its own recommendation change, which would have the broadest effect on coverage requirements. Until that formal designation is updated, patients who begin screening at 40 may face cost-sharing depending on their insurance plan.